ETHAN - ET for Male BC
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Hormone Receptor-positive Breast Cancer|Hormone Receptor Negative Breast Carcinoma
Interventions: DRUG: Tamoxifen|DRUG: Anastrozole|DRUG: Degarelix|DRUG: Abemaciclib
Sponsor: Jose Pablo Leone
Collaborators: Eli Lilly and Company|Translational Breast Cancer Research Consortium (TBCRC)